Clinical Trial Update: A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Update on a Phase 3 trial evaluating infliximab in combination with methotrexate for early rheumatoid arthritis, focusing on safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Remicade (infliximab) (infliximab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED